According to the Robert Koch Institute (RKI), the norovirus, which is widespread worldwide, is the cause of a large proportion of gastrointestinal infections. Those who catch the virus suffer from nausea, diarrhea and vomiting. It is very contagious and can spread quickly from person to person.
There is not much that can be done preventively beyond general hygiene rules. There is currently no vaccine against the norovirus. However, doctors have now begun to test the world’s first mRNA vaccine against the norovirus.
Norovirus vaccine based on mRNA technology is being tested
The vaccine is to undergo a phase three clinical trial called Nova 301. In two years, 25,000 people, mainly over 60 years old, from countries such as Japan, Canada and Australia are to be involved, reports the Guardian. Mobile teams are also to be used to make it easier for people to participate in the trial.
Half of the participants are to receive the new mRNA vaccine and the other half a saline solution as a placebo. The assignment follows at random.
Various institutions of the British National Health Service (NHS) and the pharmaceutical company Moderna, which manufactures the vaccine, are involved in the study. The norovirus vaccine is based on an mRNA technology with which the company Moderna, but also Pizer/Biontech, have already produced a vaccine against the corona virus.
In an earlier trial with the new norovirus vaccine, strong immune reactions are said to have already been detected in humans. The study is now about investigating whether the vaccine is effective against the virus itself and, if so, how long the protection lasts. “At least 65 percent (efficacy) or more is what we would consider clinically sensible,” the Guardian quotes Dr. Doran Fink of Moderna.
Norovirus is a threat to old and sick people
Norovirus outbreaks are common in hospitals, nursing homes, daycare centers or schools. Especially for very young or old people and for anyone who has a weakened immune system, an infection can have serious consequences. A successful vaccine would help ensure that operations in nursing homes could be maintained normally, says Prof. Saul Faust of the University of Southampton, according to the report.
General practitioner and study leader Dr. Patrick Moore emphasizes how high the burden of norovirus is. Worldwide, there are about 685 million cases and 200,000 deaths every year. In the UK, there are about four million cases a year.
It is hoped that a vaccine could bring health and economic benefits. “In the UK, norovirus costs the NHS an estimated £100 million a year [and] if you take into account the loss of earnings, it’s about £300 million,” says Moore.
If the result of the study is positive, it is expected that it will be possible to submit an application for approval for the vaccine in 2026. However, the review process would take another up to a year. In addition, further studies on teenagers and younger people would be needed.
News
Scientists Find Way to Turn Tumor-Protecting Cells Into Cancer Killers
A new cancer therapy wakes up immune cells inside tumors and turns them against cancer. Tumors contain immune cells called macrophages that are naturally capable of attacking cancer. However, the tumor environment blocks these [...]
Analyzing Darwin’s specimens without opening 200-year-old jars
Scientists have successfully analyzed Charles Darwin's original specimens from his HMS Beagle voyage (1831 to 1836) to the Galapagos Islands. Remarkably, the specimens have been analyzed without opening their 200-year-old preservation jars. Examining 46 [...]
Scientists discover natural ‘brake’ that could stop harmful inflammation
Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide. Inflammation is the [...]
A Forgotten Molecule Could Revive Failing Antifungal Drugs and Save Millions of Lives
Scientists have uncovered a way to make existing antifungal drugs work again against deadly, drug-resistant fungi. Fungal infections claim millions of lives worldwide each year, and current medical treatments are failing to keep pace. [...]
Scientists Trap Thyme’s Healing Power in Tiny Capsules
A new micro-encapsulation breakthrough could turn thyme’s powerful health benefits into safer, smarter nanodoses. Thyme extract is often praised for its wide range of health benefits, giving it a reputation as a natural medicinal [...]
Scientists Develop Spray-On Powder That Instantly Seals Life-Threatening Wounds
KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly improve survival in combat and emergency medicine. Severe blood loss remains the primary cause of death from [...]
Oceans Are Struggling To Absorb Carbon As Microplastics Flood Their Waters
New research points to an unexpected way plastic pollution may be influencing Earth’s climate system. A recent study suggests that microscopic plastic pollution is reducing the ocean’s capacity to take in carbon dioxide, a [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from Frank Boehm
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
New Book! NanoMedical Brain/Cloud Interface – Explorations and Implications
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
